FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of Everything You Need to Know About the FDA Peptide Ban FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner Important Update on FDA Changes Concerning Peptides